R&D Systems™ Recombinant Human LILRB5/CD85c/LIR-8 Protein

Catalog No.	Quantity
84-87T-4025	25 μg

Catalog No. 84-87T-4025 Supplier R&D Systems™ Supplier No. 8487T4025

Description

His-tag

Measured by its binding ability in a functional ELISA. When Recombinant Human LILRB5/CD85c/LIR-8 is coated at 2 μg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 (Catalog # 914-AN ) binds with an apparent Kd <4 nM.

Specifications

• Accession Number: O75023
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 10990
• Molecular Weight (g/mol): M.W. (Observed): 64-77 kDa, reducing conditions; M.W. (theoretical): 49 kDa
• Name: LILRB5/CD85c/LIR-8
• Preparation Method: Reconstitute at 100μg/mL in PBS.
• Quality Control Testing: SDS-PAGE: 64-77kDa, reducing conditions
• Quantity: 25 μg
• Source: Mouse myeloma cell line, NS0-derived human LILRB5/CD85c/LIR-8 protein Arg18-His456, with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Termination: Arg18
• Without Additives: Carrier Protein
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Symbol: LILRB5
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100 μg/mL in PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE with silver staining.
• Protein: LIR-8/CD85c/LILRB5